Vasopressin Transdermal Patch 0.4 mg/24hr from Canada
Controlled-release transdermal patch delivering 0.4 mg vasopressin over 24 hours for chronic diabetes insipidus management. Note specifies transdermal systems; classified 3004.39.0045 as measured-dose hormone product of heading 2937.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Adhesive matrix composition and permeation testing reports required for device-drug combo clearance
• Shelf-life extension data critical for transdermal stability during ocean freight